1,093 results on '"Zhao, Jizong"'
Search Results
2. Mass cytometry revealed the circulating immune cell landscape across different Suzuki stages of Moyamoya disease
3. Glymphatic Impairment Associated with Neurocognitive Dysfunction in Moyamoya Disease
4. Somatic PDGFRB activating variants promote smooth muscle cell phenotype modulation in intracranial fusiform aneurysm
5. Deep-Learning Tool for Early Identifying Non-Traumatic Intracranial Hemorrhage Etiology based on CT Scan
6. Deep Learning Approach to Predict Hemorrhage in Moyamoya Disease
7. The prognostic nutrition index is a predictor for long-term outcomes after revascularization in adult moyamoya disease
8. Statins may Decrease Aneurysm wall Enhancement of Unruptured Fusiform Intracranial Aneurysms: A high-resolution 3T MRI Study
9. Impacts of exposure to ambient temperature and altitude on the burden of stroke
10. Correction to: Human antimicrobial peptide LL-37 contributes to Alzheimer’s disease progression
11. Hybrid surgery can improve neurocognitive function in patients with internal carotid artery occlusion
12. Network neurosurgery
13. Endothelial hyperactivation of mutant MAP3K3 induces cerebral cavernous malformation enhanced by PIK3CA GOF mutation
14. Association of lysine pathway metabolites with moyamoya disease
15. Brain-Computer Interfaces in Disorders of Consciousness
16. Hemorrhage Risk in Moyamoya Disease with Fetal-Type Posterior Cerebral Artery: A Propensity Score-Matched Analysis
17. Human antimicrobial peptide LL-37 contributes to Alzheimer’s disease progression
18. Reorganization of Gray Matter Networks in Patients with Moyamoya Disease
19. Exploring the relationship between hemodynamics and the immune microenvironment in carotid atherosclerosis: Insights from CFD and CyTOF technologies
20. High glutamine increases stroke risk by inducing the endothelial‐to‐mesenchymal transition in moyamoya disease
21. Circulating immune cell landscape and T‐cell abnormalities in patients with moyamoya disease
22. 121 The Effectiveness of Deep Brain Stimulation in Patients With Disorders of Consciousness During Short- and Long-Term
23. 101 Glymphatic System Impairment Associated With Neurocognitive Dysfunction and Alzheimers Biomarkers in Moyamoya Disease
24. 309 High Glutamine Associated With the Risk of Stroke by Inducing Endothelial to Mesenchymal Transition Through ITGB4 MAPK-ERK Smad in Moyamoya Disease
25. Three-dimensional printing-assisted precision microcatheter shaping in intracranial aneurysm coiling
26. Prevalence and Procedural Risk of Intracranial Atherosclerotic Stenosis Coexisting With Unruptured Intracranial Aneurysm
27. Prognostic biomarker SGSM1 and its correlation with immune infiltration in gliomas
28. Epidemiology of Moyamoya disease in China: A nationwide hospital-based study
29. Single‐cell atlas of peripheral blood by CyTOF revealed peripheral blood immune cells metabolic alterations and neutrophil changes in intracranial aneurysm rupture.
30. Mesenchymal stem cell therapy for ischemic stroke: A look into treatment mechanism and therapeutic potential
31. Hyperhomocysteinemia is a risk factor for postoperative ischemia in adult patients with moyamoya disease
32. Reevaluating the impact of antihypertensive medication on intracranial aneurysm formation: a call for clarification and further study
33. Multiomics and blood-based biomarkers of moyamoya disease: protocol of Moyamoya Omics Atlas (MOYAOMICS)
34. Metabolic alterations of peripheral blood immune cells and heterogeneity of neutrophil in intracranial aneurysms patients
35. Brain–computer interface digital prescription for neurological disorders
36. Single-Cell Atlas of Atherosclerosis Patients by Cytof: Circulatory and Local Immune Disorders
37. Unruptured Giant Intracranial Aneurysms: Risk Factors for Mortality and Long-Term Outcome
38. Long-term outcomes and prognostic predictors of 111 pediatric hemorrhagic cerebral arteriovenous malformations after microsurgical resection: a single-center experience
39. A meta-analysis on the efficiency of the time window of hyperbaric oxygen treatment on disorders of consciousness in China
40. Association between bilateral postoperative neoangiogenesis in patients with moyamoya disease
41. Clinical characteristics and risk factors of perioperative outcomes in elderly patients with intracranial tumors
42. Identification of N6-methyladenosine-related lncRNAs for patients with primary glioblastoma
43. Clinical neuromodulatory effects of deep brain stimulation in disorder of consciousness: A literature review.
44. The association between hemoglobin concentration and clinical outcomes after aneurysmal subarachnoid hemorrhage: Insights from the LongTEAM registry.
45. Antiplatelet therapy does not increase mortality of surgical treatment for spontaneous intracerebral haemorrhage
46. Combined STA-MCA Bypass and Encephalodurosynangiosis Versus Encephalodurosynangiosis Alone in Adult Hemorrhagic Moyamoya Disease: A 5 -Year Outcome Study
47. Expression and prognostic value of mRNAs in lower grade glioma with MGMT promoter methylated
48. Comparison of clinical outcomes and characteristics between patients with and without hypertension in moyamoya disease
49. Impact of AVM location on language cortex right-hemisphere reorganization: A voxel-based lesion-symptom mapping study
50. Does ChatGPT have consciousness?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.